This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 May 8;375(9726):1606; author reply 1606-7.

doi: 10.1016/S0140-6736(10)60697-6.

Procalcitonin in intensive care units: the PRORATA trial

Gijs W Landman, Nanne Kleefstra

PMID: 20452516
DOI: 10.1016/S0140-6736(10)60697-6

Comment

Procalcitonin in intensive care units: the PRORATA trial

Gijs W Landman et al. Lancet. 2010.

. 2010 May 8;375(9726):1606; author reply 1606-7.

doi: 10.1016/S0140-6736(10)60697-6.

Authors

Gijs W Landman, Nanne Kleefstra

PMID: 20452516
DOI: 10.1016/S0140-6736(10)60697-6

No abstract available

PubMed Disclaimer

Comment on

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; PRORATA trial group. Bouadma L, et al. Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25. Lancet. 2010. PMID: 20097417 Clinical Trial.

Similar articles

Procalcitonin in intensive care units: the PRORATA trial.
Gibot S. Gibot S. Lancet. 2010 May 8;375(9726):1605-6; author reply 1606-7. doi: 10.1016/S0140-6736(10)60696-4. Lancet. 2010. PMID: 20452514 No abstract available.
Procalcitonin in intensive care units: the PRORATA trial.
Mokart D, Leone M. Mokart D, et al. Lancet. 2010 May 8;375(9726):1605; author reply 1606-7. doi: 10.1016/S0140-6736(10)60694-0. Lancet. 2010. PMID: 20452515 No abstract available.
Procalcitonin in intensive care units: the PRORATA trial.
Tarnow-Mordi W, Gebski V. Tarnow-Mordi W, et al. Lancet. 2010 May 8;375(9726):1605; author reply 1606-7. doi: 10.1016/S0140-6736(10)60695-2. Lancet. 2010. PMID: 20452513 No abstract available.
[Procalcitonin as a biomarker in infections].
Christ-Crain M. Christ-Crain M. Praxis (Bern 1994). 2007 Jun 20;96(25-26):1017-21. doi: 10.1024/1661-8157.96.25.1017. Praxis (Bern 1994). 2007. PMID: 17639964 Review. German. No abstract available.
Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
Sandifer JP, Jones AE. Sandifer JP, et al. Ann Emerg Med. 2012 Sep;60(3):370-1. doi: 10.1016/j.annemergmed.2012.01.007. Epub 2012 Feb 2. Ann Emerg Med. 2012. PMID: 22305332 Review. No abstract available.

See all similar articles

Cited by

Role of procalcitonin use in the management of sepsis.
Gregoriano C, Heilmann E, Molitor A, Schuetz P. Gregoriano C, et al. J Thorac Dis. 2020 Feb;12(Suppl 1):S5-S15. doi: 10.21037/jtd.2019.11.63. J Thorac Dis. 2020. PMID: 32148921 Free PMC article. Review.
New approaches to sepsis: molecular diagnostics and biomarkers.
Reinhart K, Bauer M, Riedemann NC, Hartog CS. Reinhart K, et al. Clin Microbiol Rev. 2012 Oct;25(4):609-34. doi: 10.1128/CMR.00016-12. Clin Microbiol Rev. 2012. PMID: 23034322 Free PMC article.
Biomarkers of Infection: Are They Useful in the ICU?
Heilmann E, Gregoriano C, Schuetz P. Heilmann E, et al. Semin Respir Crit Care Med. 2019 Aug;40(4):465-475. doi: 10.1055/s-0039-1696689. Epub 2019 Oct 4. Semin Respir Crit Care Med. 2019. PMID: 31585473 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information